Sandy R Shultz Selected Research

Brain Concussion (Cerebral Concussion)

12/2022	Targeting the Cerebrovascular System: Next-Generation Biomarkers and Treatment for Mild Traumatic Brain Injury.
1/2022	Micro-RNA levels and symptom profile after mild traumatic brain injury: A longitudinal cohort study.
12/2021	Gut microbiome depletion and repetitive mild traumatic brain injury differentially modify bone development in male and female adolescent rats.
10/2021	The Known Unknowns: An Overview of the State of Blood-Based Protein Biomarkers of Mild Traumatic Brain Injury.
1/2021	Temporal profile and utility of serum neurofilament light in a rat model of mild traumatic brain injury.
4/2020	Examining the Effects of Anabolic-Androgenic Steroids on Repetitive Mild Traumatic Brain Injury (RmTBI) Outcomes in Adolescent Rats.
1/2019	Neuroendocrine Whiplash: Slamming the Breaks on Anabolic-Androgenic Steroids Following Repetitive Mild Traumatic Brain Injury in Rats May Worsen Outcomes.
1/2018	Telomere length and advanced diffusion MRI as biomarkers for repetitive mild traumatic brain injury in adolescent rats.
1/2016	Behavioral, blood, and magnetic resonance imaging biomarkers of experimental mild traumatic brain injury.
1/2016	Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandy R Shultz Research Topics

Disease

19	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 05/2014
15	Wounds and Injuries (Trauma) 12/2021 - 01/2012
11	Brain Concussion (Cerebral Concussion) 12/2022 - 12/2015
10	Neuroinflammatory Diseases 11/2021 - 02/2013
10	Epilepsy (Aura) 10/2019 - 06/2014
9	Brain Injuries (Brain Injury) 01/2022 - 09/2012
5	Inflammation (Inflammations) 01/2022 - 02/2013
4	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 10/2019 - 01/2016
3	Multiple Trauma (Multiple Injuries) 01/2021 - 11/2017
3	Atrophy 04/2020 - 05/2014
3	Status Epilepticus (Complex Partial Status Epilepticus) 11/2019 - 01/2016
3	Autistic Disorder (Autism) 02/2015 - 05/2008
2	Infections 01/2022 - 03/2021
2	Gliosis 11/2021 - 05/2014
2	Disease Progression 10/2021 - 04/2014
2	Seizures (Absence Seizure) 11/2019 - 01/2019
2	Cognitive Dysfunction 11/2019 - 10/2011
2	Edema (Dropsy) 01/2018 - 11/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 06/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 05/2014
2	Spinal Cord Injuries (Spinal Cord Injury) 09/2015 - 09/2012
1	Pathologic Processes 11/2021
1	Pain (Aches) 01/2021
1	Heterotopic Ossification (Ectopic Ossification) 12/2020
1	Temporal Lobe Epilepsy 11/2019
1	Brain Edema (Cerebral Edema) 10/2019
1	Post-Concussion Syndrome 01/2019
1	Apnea 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2018
1	Tibial Fractures (Fracture, Tibial) 11/2017
1	Muscular Atrophy (Muscle Atrophy) 01/2017
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 09/2015

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 12/2022 - 06/2014
17	salicylhydroxamic acid (SHAM)IBA 12/2021 - 10/2011
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
3	Messenger RNA (mRNA)IBA 04/2020 - 01/2018
3	HMGB1 Protein (HMG1)IBA 01/2020 - 01/2019
3	Kainic Acid (Kainate)IBA 11/2019 - 01/2016
3	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016 - 05/2015
3	Selenic AcidIBA 01/2016 - 05/2015
3	IntegrinsIBA 09/2015 - 09/2012
3	propionic acid (potassium propionate)IBA 02/2015 - 05/2008
2	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2021
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 10/2019
2	LipopolysaccharidesIBA 01/2022 - 03/2021
2	Biological ProductsIBA 11/2021 - 01/2020
2	Anabolic Androgenic SteroidsIBA 04/2020 - 01/2019
2	Neuroprotective AgentsIBA 12/2018 - 05/2014
2	Pharmaceutical PreparationsIBA 01/2017 - 05/2015
2	Monoclonal AntibodiesIBA 02/2013 - 09/2012
1	Fatty Acid-Binding Protein 7IBA 01/2022
1	Claudin-5IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	AcidsIBA 01/2022
1	von Willebrand FactorIBA 01/2022
1	PhosphoproteinsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Drinking WaterIBA 12/2021
1	SugarsIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	InflammasomesIBA 04/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Z944IBA 11/2019
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 11/2019
1	Levetiracetam (Keppra)FDA LinkGeneric 11/2019
1	SteroidsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2018
1	gambogic amideIBA 01/2018
1	ChemokinesIBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2017
1	Progesterone FDA LinkGeneric 12/2015
1	AntioxidantsIBA 12/2015
1	EnzymesIBA 09/2015
1	tau Proteins (tau Protein)IBA 06/2014
1	TubulinIBA 06/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2014
1	CytokinesIBA 05/2014
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2012
1	Anti-Anxiety Agents (Anxiolytics)IBA 10/2011

Therapy/Procedure

11	Therapeutics 12/2020 - 02/2013
2	Electrodes (Electrode) 11/2019 - 01/2019
1	Operative Surgical Procedures 10/2019
1	Anesthesia 01/2019
1	Biological Therapy 12/2018
1	Injections 06/2009